Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Talkspace Community
NasdaqCM:TALK Community
2
Narratives
written by author
0
Comments
on narratives written by author
37
Fair Values set
on narratives written by author
Create a narrative
Talkspace
Popular
Undervalued
Overvalued
Community Investing Ideas
Talkspace
TE
TechGrowthInvestor
Community Contributor
Intervalo de avaliação de $2,06 a $3,80. Insiders compraram recentemente a $2,86
No modelo DCF a avaliação atual varia entre $2,06 com WACC 9,31% com taxa terminal de 2% (conservadora) O modelo de avaliação por comparação com os pares aponta para $2,29 O modelo Simply Wall Street com as mesmas premissas que utilizado no moderno DCF: WACC= 9,31% avalia a ação em $3,80 O PEG fwd aponta para PE =69X para 2025 e taxa crescimento EPS a médio prazo de 40% está um pouco sobrevalorida PEG=1,74. Para PEG=1 a ação estaria a cotar no 2,80 o que coincide com a cotação atual.
View narrative
US$3.71
FV
33.2% undervalued
intrinsic discount
16.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 months ago
author updated this narrative
Talkspace
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Medicare And TRICARE Expansion Will Unlock Future Potential
Key Takeaways Transition to a Payor-focused model and expansions of networks like Medicare and TRICARE promise revenue growth and improved profitability through a stable customer base. AI-driven technologies and operational efficiencies enhance member engagement and reduce costs, leading to improved net margins and increased earnings.
View narrative
US$5.19
FV
52.2% undervalued
intrinsic discount
21.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
TALK
TALK
Talkspace
Your Fair Value
US$
Current Price
US$2.48
40.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-70m
434m
2015
2018
2021
2024
2025
2027
2030
Revenue US$433.8m
Earnings US$6.5m
Advanced
Set Fair Value